Drawing for Serial No. 77531932

USPTO serial 77531932

Serial No. 77531932

Reviewed by CopyMark Law Group

Reg. 3671845Status 710
Filing date
Status date
Registration date
Aug 25, 2009
Examiner
MAYES, LAURIE ANN
Law office
TMEG LAW OFFICE 101

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with Serial No. 77531932?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Willian Squire

Willian Squire Carella Byrne Cecchi Olstein Brody & Agnello5 Becker Farm RoadROSELAND, NJ 07068UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for counteracting the effects of biological and chemical agents; pharmaceutical preparations for treating infectious diseases; antibody based pharmaceutical preparations for counteracting the effects of biological and chemical agents; antibody based pharmaceutical preparations for treating infectious diseases; vaccines; pharmaceutical preparations for treatment and prevention of Alzheimer's disease; pharmaceutical preparations for treatment and prevention of poisoning; pharmaceutical preparations for treatment and prevention of neurological disease; pharmaceutical preparations for treatment and prevention of infectious disease; recombinant based therapeutics in the nature of pharmaceutical preparations for counteracting the effects of biological and chemical agents and for treating infectious diseases; pharmaceutical preparations acting on the central nervous system for counteracting the effects of biological and chemical agents and for treating infectious diseases; pharmaceutical preparations for treatment and prevention of anthrax infection; pharmaceutical preparations for treatment and prevention of toxicity caused by cholinesterase inhibiting compoundsSECTION 8 - CANCELLEDOct 26, 2004

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 27, 2020CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Aug 25, 2018REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jun 24, 2015NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jun 24, 2015C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jun 23, 2015APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 2, 2015E815TEAS SECTION 8 & 15 RECEIVED—
Nov 18, 2010CORVREVIEW OF CORRESPONDENCE COMPLETE—
Nov 17, 2010APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 14, 2010MAILPAPER RECEIVED—
Aug 25, 2009R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 9, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 20, 2009NPUBNOTICE OF PUBLICATION—
May 6, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 6, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 3, 2009XAECEXAMINER'S AMENDMENT ENTERED—
May 1, 2009ALIEASSIGNED TO LIE—
May 1, 2009GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 1, 2009GNEAEXAMINERS AMENDMENT E-MAILED—
May 1, 2009CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 3, 2008GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 3, 2008GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 3, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 29, 2008DOCKASSIGNED TO EXAMINER—
Jul 30, 2008MDSCNOTICE OF DESIGN SEARCH CODE MAILED—
Jul 29, 2008NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance